Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06929572 · ClinicalTrials.gov registry record · NA
Autologous Human Umbilical Cord Tissue Patch for Postnatal Closure of Open Neural Tube Defects
A NA study of Spina Bifida, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT06929572 is a NA study of Spina Bifida that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 15 participants, below the 52-participant average among 16 other Spina Bifida trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06929572, a NA study of Spina Bifida, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the impact of an autologous umbilical cord patch for dural closure on the repair of open neural tube defect. The outcomes will evaluate successful defect closure, creation of a more capacious spinal canal, and reduction in inflammatory tissue response versus historical controls.
Conditions Studied
Interventions
- PROCEDURE Autologous umbilical cord patch
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2025-08-05 |
| Est. Completion | 2033-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06929572
The ClinicalTrials.gov registry entry for NCT06929572 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 52-participant average among 16 other Spina Bifida trials with a reported enrollment target (71% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Spina Bifida appearing as the primary indexed condition, and to 1 intervention - of which Autologous umbilical cord patch is the first listed.
NCT06929572 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06929572 about?
NCT06929572 is a clinical study titled "Autologous Human Umbilical Cord Tissue Patch for Postnatal Closure of Open Neural Tube Defects". The purpose of this study is to determine the impact of an autologous umbilical cord patch for dural closure on the repair of open neural tube defect. The outcomes will evaluate successful defect closure, creation of a more capacious spinal canal, and reduction in inflammatory tissue response versus...
What is the current status of trial NCT06929572?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2025-08-05. Estimated completion is 2033-01.
What conditions does trial NCT06929572 study?
This clinical trial studies the following conditions: Spina Bifida.
What interventions are being tested in trial NCT06929572?
The interventions under investigation include: Autologous umbilical cord patch (PROCEDURE).
Who is sponsoring clinical trial NCT06929572?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06929572 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spina Bifida
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
RECRUITING · NA
-
Transcutaneous Tibial Nerve Stimulation (TTNS) Treatment in Spina Bifida Pediatric Patients With Neurogenic Bladder
RECRUITING · NA
-
Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele
RECRUITING · NA
-
Transcutaneous Spinal Stimulation for Children and Youth With Spina Bifida
RECRUITING · NA
-
Mobile Health Self-Management and Support System for Chronic and Complex Health Conditions
RECRUITING · NA
-
In-Utero Endoscopic Correction of Spina Bifida
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.